Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jangmi | - |
dc.contributor.author | Boerrigter, Stephan X. M. | - |
dc.contributor.author | Jung, Young Woo | - |
dc.contributor.author | Byun, Youngjoo | - |
dc.contributor.author | Yuk, Soon Hong | - |
dc.contributor.author | Byrn, Stephen R. | - |
dc.contributor.author | Lee, Eun Hee | - |
dc.date.accessioned | 2021-09-05T19:01:18Z | - |
dc.date.available | 2021-09-05T19:01:18Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2013-11-20 | - |
dc.identifier.issn | 0928-0987 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/101590 | - |
dc.description.abstract | Tenofovir disoproxil fumarate (TDF) is a prodrug of tenofovir that belongs to a class of antiretroviral drugs, a nucleotide reverse transcriptase inhibitor. An acetonitrile solvate of TDF I, another new solvated form of TDF, was prepared and solid state characterization of its form was conducted using powder X-ray diffraction, FT-IR spectroscopy, and organic vapor sorption isotherm. During the characterization work, it was discovered that (1) TDF I can form solvates and polymorph with a wide variety of organic solvents as well as water and (2) to different extents, these solvates undergoes anisotropic lattice contraction/expansion during desolvation/solvation process suggesting the formation of isostructural solvates of TDF. Solvents used in this study include ethanol, isopropyl alcohol, acetonitrile, cyclohexane, toluene, and water. Four new solvates using ethanol, isopropyl alcohol, acetonitrile, and toluene vapor and one polymorph using water vapor were discovered. Their solid state characterizations were conducted using powder X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, and Fourier transform infrared spectroscopy. A variety of isostructural solvates and a polymorph of TDF was produced by an organic vapor sorption method, showing varying physicochemical properties. This study demonstrates an alternative crystallization method to obtain isostructural solvates. (C) 2013 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER | - |
dc.title | Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jung, Young Woo | - |
dc.contributor.affiliatedAuthor | Byun, Youngjoo | - |
dc.contributor.affiliatedAuthor | Yuk, Soon Hong | - |
dc.contributor.affiliatedAuthor | Lee, Eun Hee | - |
dc.identifier.doi | 10.1016/j.ejps.2013.07.004 | - |
dc.identifier.scopusid | 2-s2.0-84884521072 | - |
dc.identifier.wosid | 000325838800002 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, v.50, no.3-4, pp.253 - 262 | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | - |
dc.citation.title | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | - |
dc.citation.volume | 50 | - |
dc.citation.number | 3-4 | - |
dc.citation.startPage | 253 | - |
dc.citation.endPage | 262 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordAuthor | Tenofovir disoproxil fumarate | - |
dc.subject.keywordAuthor | Isostructural solvate | - |
dc.subject.keywordAuthor | Isostructural desolvate | - |
dc.subject.keywordAuthor | Solid-state characterization | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.